CM-24 is under clinical development by Purple Biotech and currently in Phase I for Non-Small Cell Lung Cancer.

Proagio is under clinical development by ProDa BioTech and currently in Phase II for Triple-Negative Breast Cancer (TNBC).

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

Autolus hopes its less gruelling Car-T treatment for a type of leukaemia will allow it to compete with bigger rivals ...

Gene Solutions, a pioneering biotech company in Asia, announced that Bui Que Tran Nguyen, a young scientist from its cancer ...

Syncromune, a biotech startup working on combination immunotherapies, has put together a $100 million Series A, the company ...

Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the ...

Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope ...

Oncolytics Biotech (TSE:ONC) has released an update ... pelareorep’s ability to enhance the effectiveness of existing cancer treatments, potentially improving patient outcomes in pancreatic ...

23, 2024 /PRNewswire/ -- Oncolytics Biotech ® Inc ... headlined by the robust efficacy results from the BRACELET-1 breast cancer study," said Wayne Pisano, Interim CEO and Chair of Oncolytics ...

IO Biotech secures €57.5 million loan facility from EIB to support cancer vaccine development, extending cash runway to 2026. IO Biotech has secured a loan facility of up to €57.5 million from ...